Astrocytes as a source for extracellular matrix molecules and cytokines

Frontiers in Pharmacology

Volumn 3 JUN, Issue , 2012, Pages

  Wiese, Stefan ^a   Karus, Michael ^a   Faissner, Andreas ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Astroglial development; Cytokines; Extracellular matrix; Reactive astrocytes; Tenascin c

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CILIARY NEUROTROPHIC FACTOR RECEPTOR; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLYCOSAMINOGLYCAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; NERVE GROWTH FACTOR; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; SMAD PROTEIN; STAT3 PROTEIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTROCYTE; CELL INTERACTION; CELL MATURATION; CELL SIZE; CELLULAR SECRETION; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DOWN REGULATION; EXTRACELLULAR MATRIX; GLIA; HUMAN; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PARKINSON DISEASE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; STEM CELL; UPREGULATION;

EID: 84866293023     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00120     Document Type: Article

References (192)

1. Agostinho, P., Cunha, R. A., and Oliveira, C. (2010). Neuroinflam-mation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr. Pharm. Des. 16, 2766-2778.
2. Akita, K., von Holst, A., Furukawa, Y., Mikami, T., Sugahara, K., and Faissner, A. (2008). Expression of multiple chondroitin/dermatan sulfotransferases in the neurogenic regions of the embryonic and adult central nervous system implies that complex chondroitin sulfates have a role in neural stem cell maintenance. Stem Cells 26, 798-809.
3. Ali, C., Docagne, F., Nicole, O., Lesné, S., Toutain, J., Young, A., Chazalviel, L., Divoux, D., Caly, M., Cabal, P., Derlon, J. M., MacKenzie, E. T., Buisson, A., and Vivien, D. (2001). Increased expression of transforming growth factor-beta after cerebral ischemia in the baboon: an endogenous marker of neuronal stress? J. Cereb. Blood Flow Metab. 21, 820-827.
4. Allen, N. J., and Barres, B. A. (2009). Neuroscience: Glia - more than just brain glue. Nature 457, 675-677.
5. Amara, F. M., Junaid, A., Clough, R. R., and Liang, B. (1999). TGF-beta(1), regulation of Alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization. Brain Res. Mol. Brain Res. 71, 42-49.
6. Ata, A. K., Funa, K., and Olsson, Y. (1997). Expression of various TGF-beta isoforms and type I receptor in necrotizing human brain lesions. Acta Neuropathol. 93, 326-333.
7. Balducci, C., and Forloni, G. (2010). APP transgenic mice: their use and limitations. Neuromolecular Med. 13, 117-137.
8. Bandtlow, C. E., and Zimmermann, D. R. (2000). Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol. Rev. 80, 1267-1290.
9. Bao, X., Mikami, T., Yamada, S., Faissner, A., Muramatsu, T., and Sugahara, K. (2005). Heparin-binding growth factor, pleiotrophin, mediates neuritogenic activity of embryonic pig brain-derived chondroitin sulfate/dermatan sulfate hybrid chains. J.Biol. Chem. 280, 9180-9191.
10. Bartsch, S., Bartsch, U., Dörries, U., Faissner, A., Weller, A., Ekblom, P., and Schachner, M. (1992). Expression of tenascin in the developing and adult cerebellar cortex. J. Neurosci. 12, 736-749.
11. Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., and Cleveland, D. W. (2006). Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389-1392.
12. Bowser, D. N., and Khakh, B. S. (2007). Vesicular ATP is the predominant cause of intercellular calcium waves in astrocytes. J. Gen. Physiol. 129, 485-491.
13. Bradbury, E. J., Moon, L. D., Popat, R. J., King, V R., Bennett, G. S., Patel, P. N., Fawcett, J. W., and McMahon, S. B. (2002). Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636-640.
14. Brambilla, R., Bracchi-Ricard, V., Hu, W. H., Frydel, B., Bramwell, A., Karmally, S., Green, E. J., and Bethea, J. R. (2005). Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 202, 145-156.
15. Bresjanac, M., and Antauer, G. (2000). Reactive astrocytes of the quinolinic acid-lesioned rat striatum express GFRalpha1 as well as GDNF in vivo. Exp.Neurol. 164, 53-59.
16. Brionne, T. C., Tesseur, I., Masliah, E., and Wyss-Coray, T. (2003). Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40,1133-1145.
17. Brodkey, J. A., Laywell, E. D., O'Brien, T. F., Faissner, A., Stefansson, K., Dörries, H. U., Schachner, M., and Steindler, D. A. (1995). Focal brain injury and upregulation of a developmentally regulated extracellular matrix protein. J. Neurosurg. 82, 106-112.
18. Buisson, A., Lesne, S., Docagne, F., Ali, C., Nicole, O., MacKenzie, E. T., and Vivien, D. (2003). Transforming growth factor-beta and ischemic brain injury. Cell. Mol. Neurobiol. 23, 539-550.
19. Burton, T., Liang, B., Dibrov, A., and Amara, F. (2002a). Transforming growth factor-beta-induced transcription of the Alzheimer beta-amyloid precursor protein gene involves interaction between the CTCF-complex and Smads. Biochem. Biophys. Res. Commun. 295, 713-723.
20. Burton, T., Liang, B., Dibrov, A., and Amara, F. (2002b). Transcriptional activation and increase in expression of Alzheimer's beta-amyloid precursor protein gene is mediated by TGF-beta in normal human astrocytes. Biochem. Biophys. Res. Commun. 295, 702-712.
21. Busch, S. A., and Silver, J. (2007). The role of extracellular matrix in CNS regeneration. Curr. Opin. Neurobiol. 17, 120-127.
22. Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., Thompson, W. J., and Barres, B. A. (2008). A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28, 264-278.
23. Campbell, I. L., Abraham, C. R., Masliah, E., Kemper, P., Inglis, J. D., Oldstone, M. B., and Mucke, L. (1993). Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. U.S.A. 90, 10061-10065.
24. Carulli, D., Laabs, T., Geller, H. M., Fawcett, J. W. (2005). Chondroitin sulfate proteoglycans in neural development and regeneration. Curr. Opin. Neurobiol. 15, 116-120.
25. Chen, J., Joon Lee, H., Jakovcevski, I., Shah, R., Bhagat, N., Loers, G., Liu, H. Y., Meiners, S., Taschenberger, G., Kügler, S., Irintchev, A., and Schachner, M. (2010). The extracellular matrix glycoprotein tenascin-C is beneficial for spinal cord regeneration.Mol. Ther. 18,1769-1777.
26. Chiquet-Ehrismann, R., and Chiquet, M. (2003). Tenascins: regulation and putative functions during pathological stress. J. Pathol. 200, 488-499.
27. Chiquet-Ehrismann, R., and Tucker, R. P. (2011). Tenascins and the importance of adhesion modulation. Cold Spring Harb. Perspect. Biol. 3. doi: 10.1101/cshperspect.a004960
28. Clement, A. M., Nadanaka, S., Masayama, K., Mandl, C., Sugahara, K., and Faissner, A. (1998). The DSD-1 carbohydrate epitope depends on sulfation, correlates with chondroitin sulfate D motifs, and is sufficient to promote neurite outgrowth. J. Biol. Chem. 273, 28444-28453.
29. Conrad, R., Jablonka, S., Sczepan, T., Sendtner, M., Wiese, S., and Klausmeyer, A. (2011). Lectin-based isolation and culture of mouse embryonic motoneurons. J. Vis. Exp. 55.
30. Czopka, T., Von Holst, A., Schmidt, G., Ffrench-Constant, C., and Faissner, A. (2009). Tenascin C and tenascin R similarly prevent the formation of myelin membranes in a RhoA-dependent manner, but antagonistically regulate the expression of myelin basic protein via a separate pathway. Glia 57,1790-1801.
31. De Groot, C. J.,Montagne, L., Barten,A. D., Sminia, P., and Van Der Valk, P. (1999). Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. J. Neuropathol. Exp. Neurol. 58, 174-187.
32. De Keyser, J., Mostert, J. P., and Koch, M. W. (2008). Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J. Neurol Sci. 267, 3-16.
33. Deller, T., Haas, C. A., Naumann, T., Joester, A., Faissner, A., and Frotscher, M. (1997). Up-regulation of astrocyte-derived tenascin-C correlates with neurite outgrowth in the rat dentate gyrus after unilateral entorhinal cortex lesion. Neuroscience 81,829-846.
34. Dobbertin, A., Czvitkovich, S., Theocharidis, U., Garwood, J., Andrews, M. R., Properzi, F., Lin, R., Fawcett, J. W., and Faissner, A. (2010). Analysis of combinatorial variability reveals selective accumulation of the fibronectin type III domains B and D of tenascin-C in injured brain. Exp. Neurol. 225, 60-73.
35. Domowicz, M. S., Sanders, T. A., Ragsdale, C. W., and Schwartz, N. B. (2008). Aggrecan is expressed by embryonic brain glia and regulates astrocyte development. Dev. Biol. 315, 114-124.
36. Drinkut, A., Tereshchenko, Y., Schulz, J. B., Bähr, M., and Kügler, S. (2011). Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery. Mol. Ther. 20, 534-543.
37. Evers, M. R., Salmen, B., Bukalo, O., Rollenhagen, A., Bösl, M. R., Morellini, E, Bartsch, U., Dityatev, A., and Schachner, M. (2002). Impairment of L-type Ca2+ channel-dependent forms of hippocampal synaptic plasticity in mice deficient in the extracellular matrix glycoprotein tenascin-C. J. Neurosci. 22, 7177-7194.
38. Faissner, A. (1997a). The tenascin gene family in axon growth and guidance. Cell Tissue Res. 290, 331-341.
39. Faissner, A. (1997b). Glial derived extracellular matrix components: important roles in axon growth and guidance. Neuroscientist 3, 371-380.
40. Faissner, A., Heck, N., Dobbertin, A., and Garwood, J. (2006). DSD-1-Proteoglycan/Phosphacan and receptor protein tyrosine phosphatase-beta isoforms during development and regeneration of neural tissues. Adv. Exp. Med. Biol. 557,25-53.
41. Faissner, A., and Kruse, J. (1990). J1/tenascin is a repulsive substrate for central nervous system neurons. Neuron 5, 627-637.
42. Faissner, A., Pyka, M., Geissler, M., Sobik, T., Frischknecht, R., Gundelfinger, E. D., and Seidenbecher, C. (2010). Contributions of astrocytes to synapse formation and maturation - potential functions of the perisynaptic extracellular matrix. Brain Res. Rev. 63,26-38.
43. Faissner, A., Scholze, A., and Götz, B. (1994a). Tenascin glycoproteins in developing neural tissues: only decoration? Perspect. Dev. Neurobiol. 2, 53-66.
44. Faissner, A., Clement, A., Lochter, A., Streit, A., Mandl, C., and Schachner, M. (1994b). Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties.J. Cell Biol. 126,783-799.
45. Faissner, A., and Steindler, D. (1995). Boundaries and inhibitory molecules in developing neural tissues. Glia 13,233-254.
46. Fawcett, J. (2009). Molecular control of brain plasticity and repair. Prog. Brain Res. 175,501-509.
47. Fawcett, J. W. (2006a). The glial response to injury and its role in the inhibition of CNS repair. Adv. Exp. Med. Biol. 557, 11-24.
48. Fawcett, J. W. (2006b). Overcoming inhibition in the damaged spinal cord. J. Neurotrauma 23, 371-383.
49. Fitch, M. T., and Silver, J. (2008). CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp. Neurol. 209,294-301.
50. Flanders, K. C., Ren, R. F., and Lippa, C. F. (1998). Transforming growth factor-betas in neurodegenerative disease. Prog. Neurobiol. 54, 71-85.
51. Ford-Perriss, M., Turner, K., Guimond, S., Apedaile, A., Haubeck, H. D., Turnbull, J., and Murphy, M. (2003). Localization of specific heparan sulfate proteoglycans during the proliferative phase of brain development. Dev. Dyn. 227, 170-184.
52. Galtrey, C. M., Kwok, J. C., Carulli, D., Rhodes, K. E., and Fawcett, J. W. (2008). Distribution and synthesis of extracellular matrix proteoglycans, hyaluronan, link proteins and tenascin-R in the rat spinal cord. Eur. J. Neurosci. 27, 1373-1390.
53. Garcion, E., Faissner, A., and Ffrench-Constant, C. (2001). Knockout mice reveal a contribution of the extracellular matrix molecule tenascin-C to neural precursor proliferation and migration. Development 128, 2485-2496.
54. Garcion, E., Halilagic, A., Faissner, A., and Ffrench-Constant, C. (2004). Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C. Development 131,3423-3432.
55. Garwood, J., Garcion, E., Dobbertin, A., Heck, N., Calco, V., Ffrench-Constant, C., and Faissner, A. (2004). The extracellular matrix glycoprotein tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet-derived growth factor. Eur. J. Neurosci. 2004. 20, 2524-2540.
56. Garwood, J., Rigato, F., Heck, N., and Faissner, A. (2001). Tenascin glycoproteins and the complementary ligand DSD-1-PG/phosphacan - structuring the neural extracellular matrix during development and repair. Restor. Neurol. Neurosci. 19, 51-64.
57. Garwood, J., Schnädelbach, O., Clement, A., Schütte, K., Bach, A., and Faissner, A. (1999). DSD-1-proteoglycan is the mouse homolog of phosphacan and displays opposing effects on neurite outgrowth dependent on neuronal lineage. J. Neurosci. 19, 3888-3899.
58. Garwood, J., Theocharidis, U., Calco, V., Dobbertin, A., and Faissner, A. (2012). Existence of tenascin-C isoforms in rat that contain the alternatively spliced AD 1 domain are developmentally regulated during hippocampal development. Cell. Mol. Neurobiol. 32, 279-287.
59. Gates, M. A., Thomas, L. B., Howard, E. M., Laywell, E. D., Sajin, B., Faissner, A., Götz, B., Silver, J., and Steindler, D. A. (1995). Cell and molecular analysis of the developing and adult mouse subventricular zone of the cerebral hemispheres. J. Comp. Neurol. 361,249-266.
60. Götz, B., Scholze, A., Clement, A., Joester, A., Schütte, K., Wigger, F., Frank, R., Spiess, E., Ekblom, P., and Faissner, A. (1996). Tenascin-C contains distinct adhesive, antiadhesive, and neurite outgrowth promoting sites for neurons. J. Cell Biol. 132,681-699.
61. Götz, M., Bolz, J., Joester, A., and Faissner, A. (1997). Tenascin-C synthesis and influence on axonal growth during rat cortical development. Eur. J. Neurosci. 9,496-506.
62. Gurevicius, K., Kuang, F., Stoenica, L., Irintchev, A., Gureviciene, I., Dityatev, A., Schachner, M., and Tanila, H. (2009). Genetic ablation of tenascin-C expression leads to abnormal hippocampal CA1 structure and electrical activity in vivo. Hippocampus 19, 1232-1246.
63. Halassa, M. M., Fellin, T., and Haydon, P. G. (2009a). Tripartite synapses: roles for astrocytic purines in the control of synaptic physiology and behavior. Neuropharmacology 57, 343-346.
64. Halassa, M. M., Florian, C., Fellin, T., Munoz, J. R., Lee, S. Y., Abel, T., Haydon, P. G., and Frank, M. G. (2009b). Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron 61, 213-219.
65. Hamby, M. E., Hewett, J. A., and Hewett, S. J. (2006). TGF-beta1 potentiates astrocytic nitric oxide production by expanding the population of astrocytes that express NOS-2. Glia 54, 566-577.
66. Hamby, M. E., Hewett, J. A., and Hewett, S. J. (2008). TGF-beta1 reduces the heterogeneity of astrocytic cyclooxygenase-2 and nitric oxide synthase-2 gene expression in a stimulus-independent manner. Prostaglandins Other Lipid Mediat. 85, 115-124.
67. Harvey, B. K., Richie, C. T., Hoffer, B. J., and Airavaara, M. (2010). Transgenic animal models of neurodegeneration based on human genetic studies. J. Neural Transm. 118,27-45.
68. Henrich-Noack, P., Prehn, J. H., and Krieglstein, J. (1996). TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms. Stroke 27, 1609-1614; discussion 1615.
69. Herrmann, J. E., Imura, T., Song, B., Qi, J.,Ao,Y., Nguyen, T. K.,Korsak,R. A., Takeda, K., Akira, S., and Sofroniew, M. V. (2008). STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 28, 7231-7243.
70. Hikino, M., Mikami, T., Faissner, A., Vilela-Silva, A. C., Pavão, M. S., and Sugahara, K. (2003). Oversulfated dermatan sulfate exhibits neurite outgrowth-promoting activity toward embryonic mouse hippocampal neurons: implications of dermatan sulfate in neuritogenesis in the brain. J. Biol. Chem. 278, 43744-43754.
71. Holley, J. E., Gveric, D., Whatmore, J. L., and Gutowski, N. J. (2005). Tenascin C induces a quiescent phenotype in cultured adult human astrocytes. Glia 52, 53-58.
72. Husmann, K., Faissner, A., and Schachner, M. (1992). Tenascin promotes cerebellar granule cell migration and neurite outgrowth by different domains in the fibronectin type III repeats. J. Cell Biol. 116, 1475-1486.
73. Ida, M., Shuo, T., Hirano, K., Tokita, Y., Nakanishi, K., Matsui, F., Aono, S., Fujita, H., Fujiwara, Y., Kaji, T., and Oohira, A. (2006). Identification and functions of chondroitin sulfate in the milieu of neural stem cells. J. Biol. Chem. 281,5982-5991.
74. Irintchev, A., Rollenhagen, A., Troncoso, E., Kiss, J. Z., and Schachner, M. (2005). Structural and functional aberrations in the cerebral cortex of tenascin-C deficient mice. Cereb. Cortex 15,950-962.
75. Ishii, M., and Maeda, N. (2008). Oversulfated chondroitin sulfate plays critical roles in the neuronal migration in the cerebral cortex. J. Biol. Chem. 283, 32610-32620.
76. Ito, Y., Hikino, M., Yajima, Y., Mikami, T., Sirko, S., von Holst, A., Faissner, A., Fukui, S., and Sugahara, K. (2005). Structural characterization of the epitopes of the monoclonal antibodies 473HD, CS-56, and MO-225 specific for chondroitin sulfate D-type using the oligosaccharide library. Glycobiology 15, 593-603.
77. Joester, A., and Faissner, A. (1999). Evidence for combinatorial variability of tenascin-C isoforms and developmental regulation in the mouse central nervous system. J. Biol. Chem. 274, 17144-17151.
78. Joester, A., and Faissner, A. (2001). The structure and function of tenascins in the nervous system. Matrix Biol. 20,13-22.
79. Jones, F. S., and Jones, P. L. (2000). The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev. Dyn. 218, 235-259.
80. Kabos, P., Matundan, H., Zandian, M., Bertolotto, C., Robinson, M. L., Davy, B. E., Yu, J. S., and Krueger, R. C. Jr. (2004). Neural precursors express multiple chondroitin sulfate proteoglycans, including the lectican family. Biochem. Biophys. Res. Commun. 318, 955-963.
81. Karus, M., Denecke, B., Ffrench-Constant, C., Wiese, S., and Faissner, A. (2011). The extracellular matrix molecule tenascin C modulates expression levels and territories of key patterning genes during spinal cord astrocyte specification. Development 138,5321-5331.
82. Kauppinen, R. A., Holopainen, I., Enkvist, K., and Akerman, K. E. (1989). Astroglia - more than a neural glue. Duodecim 105,498-506.
83. Kazanis, I., Belhadi, A., Faissner, A., and Ffrench-Constant, C. (2007). The adult mouse subependymal zone regenerates efficiently in the absence of tenascin-C. J. Neurosci. 27, 13991-13996.
84. Kettenmann, H., and Verkhratsky, A. (2011). [Neuroglia - living nerve glue]. Fortschr. Neurol. Psychiatr. 79, 588-597.
85. Khakh, B. S., and North, R. A. (2006). P2X receptors as cell-surface ATP sensors in health and disease. Nature 442,527-532.
86. Kiefer, R., Gold, R., Gehrmann, J., Lindholm, D., Wekerle, H., and Kreutzberg, G. W. (1993a). Transforming growth factor beta expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis. J. Neurosci. Res. 36, 391-398.
87. Kiefer, R., Lindholm, D., and Kreutzberg, G. W. (1993b). Interleukin-6 and transforming growth factor-beta 1 mRNAs are induced in rat facial nucleus following motoneuron axotomy. Eur. J. Neurosci. 5,775-781.
88. Kiefer, R., Streit, W. J., Toyka, K. V., Kreutzberg, G. W., and Hartung, H. P. (1995). Transforming growth factor-beta 1: a lesion-associated cytokine of the nervous system. Int. J. Dev. Neurosci. 13, 331-339.
89. Klausmeyer, A., Conrad, R., Faissner, A., and Wiese, S. (2011). Influence of glial-derived matrix molecules, especially chondroitin sulfates, on neurite growth and survival of cultured mouse embryonic motoneurons.J. Neurosci. Res. 89, 127-141.
90. Kleene, R., and Schachner, M. (2004). Glycans and neural cell interactions. Nat. Rev. Neurosci. 5, 195-208.
91. Kornblum, H. I., Hussain, R., Wiesen, J., Miettinen, P., Zurcher, S. D., Chow, K., Derynck, R., and Werb, Z. (1998). Abnormal astrocyte development and neuronal death in mice lacking the epidermal growth factor receptor. J. Neurosci. Res. 53, 697-717.
92. Krupinski, J., Vodovotz, Y., Li, C., Slowik, A., Beevers, D., Flanders, K. C., Lip, G., Kumar, P., and Szczudlik,A. (1998). Inducible nitric oxide production and expression of transforming growth factor-beta1 in serum and CSF after cerebral ischaemic stroke in man. Nitric Oxide 2,442-453.
93. Kwok, J. C., Afshari, F., García-Alías, G., and Fawcett, J. W. (2008). Proteoglycans in the central nervous system: plasticity, regeneration and their stimulation with chondroitinase ABC. Restor. Neurol. Neurosci. 26, 131-145.
94. Lang, A. E., Gill, S., Patel, N. K., Lozano, A., Nutt, J. G., Penn, R., Brooks, D. J., Hotton, G., Moro, E., Heywood, P., Brodsky, M. A., Burchiel, K., Kelly, P., Dalvi, A., Scott, B., Stacy, M., Turner, D., Wooten, V. G., Elias, W. J., Laws, E. R., Dhawan, V., Stoessl, A. J., Matcham, J., Coffey, R. J., and Traub, M. (2006). Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann. Neurol. 59, 459-466.
95. Lathia, J. D., Patton, B., Eckley, D. M., Magnus, T., Mughal, M. R., Sasaki, T., Caldwell, M. A., Rao, M. S., Mattson, M. P., and Ffrench-Constant, C. (2007). Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. J. Comp. Neurol. 505, 630-643.
96. Laywell, E. D., Dörries, U., Bartsch, U., Faissner, A., Schachner, M., and Steindler, D. A. (1992). Enhanced expression of the developmentally regulated extracellular matrix molecule tenascin following adult brain injury. Proc. Natl. Acad. Sci. U.S.A. 89, 2634-2638.
97. Lehre, K. P., Levy, L. M., Ottersen, O. P., Storm-Mathisen, J., and Danbolt, N. C. (1995). Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J. Neurosci. 15(3 PT 1), 1835-1853.
98. Lesné, S., Docagne, F., Gabriel, C., Liot, G., Lahiri, D. K., Buée, L., Plawinski, L., Delacourte, A., MacKenzie, E. T., Buisson, A., and Vivien, D. (2003). Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. J. Biol. Chem. 278, 18408-18418.
99. Lochter, A., Vaughan, L., Kaplony, A., Prochiantz, A., Schachner, M., and Faissner, A. (1991). J1/tenascin in substrate-bound and soluble form displays contrary effects on neurite outgrowth. J. Cell Biol. 113, 1159-1171.
100. Mahler, M., Ben-Ari, Y., and Represa, A. (1997). Differential expression of fibronectin, tenascin-C and NCAMs in cultured hippocampal astrocytes activated by kainate, bacterial lipopolysaccharide or basic fibroblast growth factor. Brain Res. 775, 63-73.
101. Maleski, M., and Hockfield, S. (1997). Glial cells assemble hyaluronanbased pericellular matrices in vitro. Glia 20,193-202.
102. Marks, W. J. Jr., Bartus, R. T., Siffert, J., Davis, C. S., Lozano, A., Boulis, N., Vitek, J., Stacy, M., Turner, D., Verhagen, L., Bakay, R., Watts, R., Guthrie, B., Jankovic, J., Simpson, R., Tagliati, M., Alterman, R., Stern, M., Baltuch, G., Starr, P. A., Larson, P. S., Ostrem, J. L., Nutt, J., Kieburtz, K., Kordower, J. H., and Olanow, C. W (2010). Gene delivery of AAV2-neurturin for Parkinson's disease: a doubleblind, randomised, controlled trial. Lancet Neurol. 9, 1164-1172.
103. Massey, J. M., Amps, J., Viapiano, M. S., Matthews, R. T., Wagoner, M. R., Whitaker, C. M., Alilain, W., Yonkof, A. L., Khalyfa, A., Cooper, N. G., Silver, J., and Onifer, S. M. (2008). Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp. Neurol. 209, 426-445.
104. Mattson, M. P., Barger, S. W., Furukawa, K.,Bruce, A. J.,Wyss-Coray,T.,Mark, R. J., and Mucke, L. (1997). Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. Brain Res. Brain Res. Rev. 23,47-61.
105. McGeer, P. L., and McGeer, E. G. (2008). Glial reactions in Parkinson's disease. Mov. Disord. 23, 474-483.
106. McKeon, R. J., Schreiber, R. C., Rudge, J. S., and Silver, J. (1991). Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci. 11, 3398-3411.
107. Meeuwsen, S., Persoon-Deen, C., Bsibsi, M., Ravid, R., and van Noort, J. M. (2003). Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia 43, 243-253.
108. Meiners, S., and Geller, H. M. (1997). Long and short splice variants of human tenascin differentially regulate neurite outgrowth. Mol. Cell. Neurosci. 10, 100-116.
109. Meiners, S., Marone, M., Rittenhouse, J. L., and Geller, H. M. (1993). Regulation of astrocytic tenascin by basic fibroblast growth factor. Dev. Biol. 160,480-493.
110. Meiners, S., Mercado, M. L., Nur-e-Kamal, M. S., and Geller, H. M. (1999). Tenascin-C contains domains that independently regulate neurite outgrowth and neurite guidance.J. Neurosci. 19,8443-8453.
111. Meiners, S., Nur-e-Kamal, M. S., and Mercado, M. L. (2001). Mercado, Identification of a neurite outgrowth-promoting motif within the alternatively spliced region of human tenascin-C. J. Neurosci. 21, 7215-7225.
112. Mena, M. A., and García de Yébenes, J. (2008). Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia. Neuroscientist 14, 544-560.
113. Mercado, M. L., Nur-e-Kamal, A., Liu, H. Y., Gross, S. R., Movahed, R., and Meiners, S. (2004). Neurite outgrowth by the alternatively spliced region of human tenascin-C is mediated by neuronal alpha7beta1 integrin. J. Neurosci. 24, 238-247.
114. Michele, M., and Faissner, A. (2009). Tenascin-C stimulates contactindependent neurite outgrowth via activation of phospholipase C. Mol. Cell. Neurosci. 2009. 41, 397-408.
115. Milev, P., Monnerie, H., Popp, S., Margolis, R. K., and Margolis, R. U. (1998). The core protein of the chondroitin sulfate proteoglycan phosphacan is a high-affinity ligand of fibroblast growth factor-2 and potentiates its mitogenic activity. J. Biol. Chem. 273,21439-21442.
116. Miyazawa, K., Shinozaki, M., Hara, T., Furuya, T., and Miyazono, K. (2002). Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 7,1191-1204.
117. Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Kogure, O., Kuno, S., Ichinose, H., and Nagatsu, T. (2001). Glial cell line-derived neurotrophic factor in the substantia nigra from control and parkinsonian brains. Neurosci. Lett. 300,179-181.
118. Morgan, T. E., Nichols, N. R., Pasinetti, G. M., and Finch, C. E. (1993). TGF-beta 1 mRNA increases in macrophage/microglial cells of the hippocampus in response to deafferentation and kainic acid-induced neurodegeneration. Exp. Neurol. 120,291-301.
119. Moritz, S., Lehmann, S., Faissner, A., and von Holst, A. (2008). An induction gene trap screen in neural stem cells reveals an instructive function of the niche and identifies the splicing regulator sam68 as a tenascin-C-regulated target gene. Stem Cells 26, 2321-2331.
120. Nadanaka, S., Clement, A., Masayama, K., Faissner, A., and Sugahara, K. (1998). Characteristic hexasaccharide sequences in octasaccharides derived from shark cartilage chondroitin sulfate D with a neurite outgrowth promoting activity. J. Biol. Chem. 273, 3296-3307.
121. Nagelhus, E. A., Mathiisen, T. M., and Ottersen, O. P. (2004). Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with KIR4.1. Neuroscience 129,905-913.
122. Nakagawa, T., and Schwartz, J. P. (2004). Gene expression profiles of reactive astrocytes in dopamine-depleted striatum. Brain Pathol. 14, 275-280.
123. Nakashima, K., Wiese, S., Yanagisawa, M., Arakawa, H., Kimura, N., Hisatsune, T., Yoshida, K., Kishimoto, T., Sendtner, M., and Taga, T. (1999). Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation. J. Neurosci. 19,5429-5434.
124. Nakic, M., Mitrovic, N., Sperk, G., and Schachner, M. (1996). Kainic acid activates transient expression of tenascin-C in the adult rat hippocampus. J. Neurosci. Res. 44, 355-362.
125. Neary, J. T., Kang, Y., and Shi, Y. F. (2004). Signaling from nucleotide receptors to protein kinase cascades in astrocytes. Neurochem. Res. 29, 2037-2042.
126. Neary, J. T., Kang, Y., Willoughby K. A., and Ellis, E. F. (2003). Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 purinergic receptors. J. Neurosci. 23,2348-2356.
127. Nicholson, C., and Sykova, E. (1998). Extracellular space structure revealed by diffusion analysis. Trends Neurosci. 21,207-215.
128. Niquet, J., Jorquera, I., Faissner, A., Ben-Ari, Y., and Represa, A. (1995). Gliosis and axonal sprouting in the hippocampus of epileptic rats are associated with an increase of tenascin-C immunoreactivity. J. Neurocytol. 24, 611-624.
129. Ochs, G., Penn, R. D., York, M., Giess, R., Beck, M., Tonn, J., Haigh, J., Malta, E., Traub, M., Sendtner, M., and Toyka, K. V. (2000). A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph. Lateral. Scler. Other Motor Neuron Disord. 1, 201-206.
130. Peng, W., Cotrina, M. L., Han, X., Yu, H., Bekar, L., Blum, L., Takano, T., Tian, G. F., Goldman, S. A., and Nedergaard, M. (2009). Systemic administration of an antagonist of the ATP-sensitive receptor P2 x 7 improves recovery after spinal cord injury. Proc. Natl. Acad. Sci. U.S.A. 106, 12489-12493.
131. Penkowa, M., Camats, J., Hadberg, H., Quintana, A., Rojas, S., Giralt, M., Molinero, A., Campbell, I. L., and Hidalgo, J. (2003). Astrocytetargeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide. J. Neurosci. Res. 73, 481-496.
132. Peress, N. S., Perillo, E., and Seidman, R. J. (1996). Glial transforming growth factor (TGF)-beta isotypes in multiple sclerosis: differential glial expression of TGF-beta 1, 2 and 3 isotypes in multiple sclerosis. J. Neuroimmunol. 71, 115-123.
133. Pizzorusso, T., Medini, P., Berardi, N., Chierzi, S., Fawcett, J. W., and Maffei, L. (2002). Reactivation of ocular dominance plasticity in the adult visual cortex. Science 298, 1248-1251.
134. Prehn, J. H., Backhauss, C., and Krieglstein, J. (1993). Transforming growth factor-beta 1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J. Cereb. Blood Flow Metab. 13, 521-525.
135. Prieto, A. L., Jones, F. S., Cunningham, B. A., Crossin, K. L., and Edelman, G. M. (1990). Localization during development of alternatively spliced forms of cytotactin mRNA by in situ hybridization. J. Cell Biol. 111,685-698.
136. Properzi, F., Carulli, D., Asher, R. A., Muir, E., Camargo, L. M., van Kuppevelt, T. H., ten Dam, G. B., Furukawa, Y., Mikami, T., Sugahara, K., Toida, T., Geller, H. M., and Fawcett, J. W. (2005). Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injuryrelated cytokines and enhanced in axon-growth inhibitory glia. Eur. J. Neurosci. 21,378-390.
137. Quintana, A., Müller, M., Frausto, R. E, Ramos, R., Getts, D. R., Sanz, E., Hofer, M. J., Krauthausen, M., King, N. J., Hidalgo, J., and Campbell, I. L. (2009). Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis. J. Immunol. 183,2079-2088.
138. Rauch, U., Clement, A., Retzler, C., Fröhlich, L., Fässler, R., Göhring, W., and Faissner, A. (1997). Mapping of a defined neurocan binding site to distinct domains of tenascin-C. J. Biol. Chem. 272,26905-26912.
139. Rigato, F., Garwood, J., Calco, V., Heck, N., Faivre-Sarrailh, C., and Faissner, A. (2002). Tenascin-C promotes neurite outgrowth of embryonic hippocampal neurons through the alternatively spliced fibronectin type III BD domains via activation of the cell adhesion molecule F3/contactin. J. Neurosci. 22, 6596-6609.
140. Rossi, D., Brambilla, L., Valori, C. F., Roncoroni, C., Crugnola, A., Yokota, T., Bredesen, D. E., and Volterra, A. (2008). Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ. 15, 1691-1700.
141. Rossi, D., and Volterra, A. (2009). Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res. Bull. 80, 224-232.
142. Schmidt, S., Linnartz, B., Mendritzki, S., Sczepan, T., Lübbert, M., Stichel, C. C., and Lübbert, H. (2011). Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria. Hum. Mol. Genet. 20,1197-1211.
143. Schweizer, U., Gunnersen, J., Karch, C., Wiese, S., Holtmann, B., Takeda, K., Akira, S., and Sendtner, M. (2002). Conditional gene ablation of Stat3 reveals differential signaling requirements for survival of motoneurons during development and after nerve injury in the
144. Sendtner, M., Hughes, R. A., Dittrich, F., Holtmann, B., Masu, Y., Carroll, P., Ochs, G., Toyka, K. V., and Thoenen, H. (1995). Ciliary neurotrophic factor (CNTF): physiological and pharmacological effects. Restor. Neurol. Neurosci. 8, 95-96.
145. Shigetomi, E., Kracun, S., Sofroniew, M. V., and Khakh, B. S. (2010). A genetically targeted optical sensor to monitor calcium signals in astrocyte processes. Nat. Neurosci. 13, 759-766.
146. Siddiqui, S., Horvat-Bröcker, A., and Faissner, A. (2008). The gliaderived extracellular matrix glycoprotein tenascin-C promotes embryonic and postnatal retina axon outgrowth via the alternatively spliced fibronectin type III domain TNfnD. Neuron Glia Biol. 4, 271-283.
147. Siddiqui, S., Horvat-Broecker, A., and Faissner, A. (2009). Comparative screening of glial cell types reveals extracellular matrix that inhibits retinal axon growth in a chondroitinase ABC-resistant fashion. Glia 57, 1420-1438.
148. Silver, J., and Miller, J. H. (2004). Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5,146-156.
149. Sirko, S., Neitz, A., Mittmann, T., Horvat-Bröcker, A., von Holst, A., Eysel, U. T., and Faissner, A. (2009). Focal laser-lesions activate an endogenous population of neural stem/progenitor cells in the adult visual cortex. Brain 132(Pt 8), 2252-2264.
150. Sirko, S., von Holst, A., Weber, A., Wizenmann, A., Theocharidis, U., Götz, M., and Faissner, A. (2010a). Chondroitin sulfates are required for fibroblast growth factor-2-dependent proliferation and maintenance in neural stem cells and for epidermal growth factor-dependent migration of their progeny. Stem Cells 28, 775-787.
151. Sirko, S., Akita, K., Von Holst, A., and Faissner, A. (2010b). Structural and functional analysis of chondroitin sulfate proteoglycans in the neural stem cell niche. Meth. Enzymol. 479, 37-71.
152. Sirko, S., von Holst, A., Wizenmann, A., Götz, M., and Faissner, A. (2007). Chondroitin sulfate glycosamino-glycans control proliferation, radial glia cell differentiation and neurogenesis in neural stem/progenitor cells. Development 134, 2727-2738.
153. Smith, C., Berry, M., Clarke, W E., and Logan, A. (2001). Differential expression of fibroblast growth factor-2 and fibroblast growth factor receptor 1 in a scarring and nonscarring model of CNS injury in the rat. Eur. J. Neurosci. 13, 443-456.
154. Smith, G. M., and Hale, J. H. (1997). Macrophage/microglia regulation of astrocytic tenascin: synergistic action of transforming growth factor-beta and basic fibroblast growth factor. J. Neurosci. 17, 9624-9633.
155. Smith, G. M., and Strunz, C. (2005). Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes. Glia 52, 209-218.
156. Smith-Thomas, L. C., Fok-Seang, J., Stevens, J., Du, J. S., Muir, E., Faissner, A., Geller, H. M., Rogers, J. H., and Fawcett, J. W. (1994). An inhibitor of neurite outgrowth produced by astrocytes. J. Cell. Sci. 107(Pt6), 1687-1695.
157. Smith-Thomas, L. C., Stevens, J., Fok-Seang, J., Faissner, A., Rogers, J. H., and Fawcett, J. W (1995). Increased axon regeneration in astrocytes grown in the presence of proteoglycan synthesis inhibitors. J. Cell. Sci. 108(Pt3), 1307-1315.
158. Sofroniew, M. V. (2009). Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32, 638-647.
159. Sofroniew, M. V., and Vinters, H. V. (2009). Astrocytes: biology and pathology. Acta Neuropathol. 119, 7-35.
160. Solano, R. M., Casarejos, M. J., Menéndez-Cuervo, J., Rodriguez-Navarro, J. A., García de Yébenes, J., and Mena, M. A. (2008). Glial dysfunction in parkin null mice: effects of aging. J. Neurosci. 28, 598-611.
161. Spooren, A., Kooijman, R., Lintermans, B., Van Craenenbroeck, K., Vermeulen, L., Haegeman, G., and Gerlo, S. (2010). Cooperation of NFkappaB and CREB to induce synergistic IL-6 expression in astrocytes. Cell. Signal. 22, 871-881.
162. Sriram, K., Benkovic, S. A., Hebert, M. A., Miller, D. B., and O'Callaghan, J. P. (2004). Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo? J. Biol. Chem. 279, 19936-19947.
163. Stichel, C. C., Zhu, X. R., Bader, V., Linnartz, B., Schmidt, S., and Lüb-bert, H. (2007). Mono- and doublemutant mouse models of Parkinson's disease display severe mitochondrial damage. Hum. Mol. Genet. 16,2377-2393.
164. Stöckli, K. A., Lillien, L. E., Näher-Noé, M., Breitfeld, G., Hughes, R. A., Raff, M. C., Thoenen, H., and Sendtner, M. (1991). Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain. J. Cell Biol. 115,447-459.
165. Stöckli, K. A., Lottspeich, F., Sendtner, M.,Masiakowski, P., Carroll, P., Götz, R., Lindholm, D., and Thoenen, H. (1989). Molecular cloning, expression and regional distribution of rat ciliary neurotrophic factor. Nature 342,920-923.
166. Strekalova, T., Sun, M., Sibbe, M., Evers, M., Dityatev, A., Gass, P., and Schachner, M. (2002). Fibronectin domains of extracellular matrix molecule tenascin-C modulate hippocampal learning and synaptic plasticity. Mol. Cell. Neurosci. 21, 173-187.
167. Tang, X., Davies, J. E., and Davies, S. J. (2003). Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J. Neurosci. Res. 71,427-444.
168. Taylor, J., Pesheva, P., and Schachner, M. (1993). Influence of janusin and tenascin on growth cone behavior in vitro. J. Neurosci. Res. 35, 347-362.
169. Theodosis, D. T., Pierre, K., Cadoret, M. A., Allard, M., Faissner, A., and Poulain, D. A. (1997). Expression of high levels of the extracellular matrix glycoprotein, tenascin-C, in the normal adult hypothalamoneurohypophysial system.J. Comp.Neurol. 379, 386-398.
170. Thomson, C. E., Linington, C., Arthur, A. T., McClure, J. D., McBride, M. W., and Barnett, S. C. (2011). Functional duality of astrocytes in myelination. J. Neurosci. 31,13028-13038.
171. Treloar, H. B., Ray, A., Dinglasan, L. A., Schachner, M., and Greer, C. A. (2009). Tenascin-C is an inhibitory boundary molecule in the developing olfactory bulb. J. Neurosci. 29, 9405-9416.
172. Tucker, R. P., Drabikowski, K., Hess, J. F., Ferralli, J., Chiquet-Ehrismann, R., and Adams, J. C. (2006). Phylogenetic analysis of the tenascin gene family: evidence of origin early in the chordate lineage. BMC Evol. Biol. 6, 60.
173. Ueoka, C., Kaneda, N., Okazaki, I., Nadanaka, S., Muramatsu, T., and Sugahara, K. (2000). Neuronal cell adhesion, mediated by the heparin-binding neuroregulatory factor midkine, is specifically inhibited by chondroitin sulfate E. Structural ans functional implications of the oversulfated chondroitin sulfate. J. Biol. Chem. 275, 37407-37413.
174. Vawter, M. P., Dillon-Carter, O., Tourtel-lotte, W. W., Carvey, P., and Freed, W. J. (1996). TGFbeta1 and TGF-beta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. Exp. Neurol. 142, 313-322.
175. Verma, P., Garcia-Alias, G., and Fawcett, J. W. (2008). Spinal cord repair: bridging the divide. Neurorehabil. Neural. Repair 22, 429-437.
176. Vincent, A. J., Gasperini, R., Foa, L., and Small, D. H. (2010). Astrocytes in Alzheimer's disease: emerging roles in calcium dysregulation and synaptic plasticity. J. Alzheimers Dis. 22, 699-714.
177. Virchow, R. (1856). Gesammelte Abhandlungen zur wissenschaftlichen Medicin. Frankfurt am: Taf, 1-1024.
178. Volterra, A., and Meldolesi, J. (2005). Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 6, 626-640.
179. von Holst, A., Egbers, U., Prochiantz, A., and Faissner, A. (2007). Neural stem/progenitor cells express 20 tenascin C isoforms that are differentially regulated by Pax6. J. Biol. Chem. 282,9172-9181.
180. von Holst, A., Sirko, S., and Faissner, A. (2006). The unique 473HD-Chondroitinsulfate epitope is expressed by radial glia and involved in neural precursor cell proliferation. J. Neurosci. 26, 4082-4094.
181. Wang, X., Arcuino, G., Takano, T., Lin, J., Peng, W. G., Wan, P., Li, P., Xu, Q., Liu, Q. S., Goldman, S. A., and Nedergaard, M. (2004). P2 x 7 receptor inhibition improves recovery after spinal cord injury. Nat. Med. 10, 821-827.
182. Wang,X., Yue, T. L., White, R. F., Barone, F. C., and Feuerstein, G. Z. (1995). Transforming growth factor-beta 1 exhibits delayed gene expression following focal cerebral ischemia. Brain Res. Bull. 36, 607-609.
183. Wang, Y., Moges, H., Bharucha, Y., and Symes, A. (2007). Smad3 null mice display more rapid wound closure and reduced scar formation after a stab wound to the cerebral cortex. Exp. Neurol. 203, 168-184.
184. Wanner, I. B., Deik, A., Torres, M., Rosendahl, A., Neary, J. T., Lemmon, V P., and Bixby, J. L. (2008). A new in vitro model of the glial scar inhibits axon growth. Glia 56, 1691-1709.
185. Wyss-Coray, T., Masliah, E., Mallory, M., McConlogue, L., Johnson-Wood, K., Lin, C., and Mucke, L. (1997). Amyloidogenic role of cytokine TGFbeta1 in transgenic mice and in Alzheimer's disease. Nature 389, 603-606.
186. Yagi, H., Yanagisawa, M., Suzuki, Y., Nakatani, Y., Ariga, T., Kato, K., and Yu, R. K. (2010). HNK-1 epitopecarrying tenascin-C spliced variant regulates the proliferation of mouse embryonic neural stem cells. J. Biol. Chem. 285, 37293-37301.
187. Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., Takahashi, R., Misawa,H.,andCleveland,D.W. (2008). Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11,251-253.
188. Yanagisawa, M., Nakashima, K., and Taga, T. (1999). STAT3-mediated astrocyte differentiation from mouse fetal neuroepithelial cells by mouse oncostatin M. Neurosci. Lett. 269, 169-172.
189. Yu, Y. M., Cristofanilli, M., Valiveti, A., Ma, L., Yoo, M., Morellini, E, and Schachner, M. (2011). The extracellular matrix glycoprotein tenascin-C promotes locomotor recovery after spinal cord injury in adult zebrafish. Neuroscience 183, 238-250.
190. Zetterberg, H., Andreasen, N., and Blennow, K. (2004). Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease. Neurosci. Lett. 367, 194-196.
191. Zhang, Y., Winterbottom, J. K., Schachner, M., Lieberman, A. R., and Anderson, P. N. (1997). Tenascin-C expression and axonal sprouting following injury to the spinal dorsal columns in the adult rat. J. Neurosci. Res. 49, 433-450.
192. Zou, P., Zou, K., Muramatsu, H., Ichihara-Tanaka, K., Habuchi, O., Ohtake, S., Ikematsu, S., Sakuma, S., and Muramatsu, T. (2003). Glycosaminoglycan structures required for strong binding to midkine, a heparin-binding growth factor. Glycobiology 13, 35-42.